Variant report
Variant | esv3364172 |
---|---|
Chromosome Location | chr6:68032031-68034379 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:68028783..68032532-chr6:68036632..68039695,4 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs537671708 | chr6:68032042-68032043 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs532620529 | chr6:68032131-68032132 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs151337413 | chr6:68032136-68032137 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs180999654 | chr6:68032152-68032153 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs35160567 | chr6:68032200-68032201 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs185020437 | chr6:68032215-68032216 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs189959994 | chr6:68032224-68032225 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs13212110 | chr6:68032226-68032227 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs140597791 | chr6:68032232-68032233 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs569428333 | chr6:68032257-68032258 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs114375948 | chr6:68032260-68032261 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs373592792 | chr6:68032261-68032262 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs78601490 | chr6:68032325-68032326 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs368033961 | chr6:68032348-68032349 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs537542837 | chr6:68032367-68032368 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs571993219 | chr6:68032403-68032404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs541011005 | chr6:68032437-68032438 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs13212494 | chr6:68032441-68032442 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs181181952 | chr6:68032444-68032445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs544050297 | chr6:68032491-68032492 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs187035344 | chr6:68032501-68032502 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs532721458 | chr6:68032504-68032505 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs547914102 | chr6:68032529-68032530 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs571831279 | chr6:68032571-68032572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs145365633 | chr6:68032574-68032575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs559791181 | chr6:68032601-68032602 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs4463242 | chr6:68032642-68032643 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs548134131 | chr6:68032658-68032659 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs567246643 | chr6:68032675-68032676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs4394193 | chr6:68032686-68032687 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs549650719 | chr6:68032700-68032701 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs569543186 | chr6:68032701-68032702 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs191425830 | chr6:68032724-68032725 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs183390366 | chr6:68032729-68032730 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs112610921 | chr6:68032730-68032731 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs565726212 | chr6:68032750-68032751 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs576284857 | chr6:68032782-68032783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs368429799 | chr6:68032783-68032784 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs534324598 | chr6:68032927-68032928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs372321482 | chr6:68032931-68032932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs578080385 | chr6:68032932-68032933 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs543906767 | chr6:68032940-68032941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs557501752 | chr6:68032942-68032943 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs574121039 | chr6:68032946-68032947 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs542849264 | chr6:68032948-68032949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs554575345 | chr6:68032963-68032964 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs544144573 | chr6:68032969-68032970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs75690461 | chr6:68032975-68032976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs199843364 | chr6:68033063-68033064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs537772920 | chr6:68033102-68033103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 20164919 | CNVD |
Wilms tumour | 21544195 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:68030400-68035600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr6:68031800-68032400 | Enhancers | Pancreatic Islets | Pancreatic Islet |